# OnCo record galena-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/galena-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "galena-biopharma" ;
  schema:name "Galena Biopharma"@en ;
  schema:alternateName "Galena Biopharma, Inc."@en, "RXi Pharmaceuticals"@en, "SELLAS Life Sciences"@en ;
  schema:description "Galena was the company behind NeuVax, a HER2 peptide vaccine meant to stop early breast cancer returning; the phase 3 PRESENT trial was stopped for futility in 2016 and Galena merged into SELLAS."@en ;
  schema:url <https://onco.cc/companies/galena-biopharma/>, <http://galenabiopharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Galena_Biopharma> ;
  owl:sameAs <http://www.wikidata.org/entity/Q5518376> ;
  schema:citation <http://galenabiopharma.com>, <https://clinicaltrials.gov/search?lead=Galena%20Biopharma%2C%20Inc.>, <https://www.wikidata.org/wiki/Q5518376> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct04588922/>, <https://onco.cc/trials/nct04229979/> .